PI3K regulatory subunits lose control in cancer
- PMID: 19962660
- DOI: 10.1016/j.ccr.2009.11.017
PI3K regulatory subunits lose control in cancer
Erratum in
- Cancer Cell. 2010 Feb 17;17(2):213. Martin-Berenjeno, Inma [corrected to Berenjeno, Inma Martin]
Abstract
The PI3K signaling axis is frequently activated in cancer resulting from inactivation of its negative regulator PTEN or activating mutations of the p110alpha catalytic subunit of PI3K. In this issue of Cancer Cell, Jaiswal et al. report that mutations in the p85alpha regulatory subunit of PI3K can also activate this pathway in cancer.
Comment on
-
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.Cancer Cell. 2009 Dec 8;16(6):463-74. doi: 10.1016/j.ccr.2009.10.016. Cancer Cell. 2009. PMID: 19962665 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
